On this episode of Let’s be Blunt, Montel talks with Michael Sassano, CEO of Somai Pharmaceuticals, a large-scale manufacturer of medical canna compounds based in Portugal. His experience as both a developer and banker in the United States and Europe provides a unique perspective towards navigating international rules and regulations for developing canna medicines.